Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
2009-7-16
pubmed:abstractText
Gene amplification status of the epidermal growth factor receptor (EGFR) and the human epidermal growth factor receptor 2 (HER2) were analyzed and correlated with clinical outcome in patients with progressive malignant salivary glands tumors (MSGT) treated with the dual EGFR/Her2 tyrosine kinase inhibitor lapatinib.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19309723-10402521, http://linkedlifedata.com/resource/pubmed/commentcorrection/19309723-10561247, http://linkedlifedata.com/resource/pubmed/commentcorrection/19309723-11370765, http://linkedlifedata.com/resource/pubmed/commentcorrection/19309723-12112535, http://linkedlifedata.com/resource/pubmed/commentcorrection/19309723-12653946, http://linkedlifedata.com/resource/pubmed/commentcorrection/19309723-12907212, http://linkedlifedata.com/resource/pubmed/commentcorrection/19309723-12953099, http://linkedlifedata.com/resource/pubmed/commentcorrection/19309723-1353853, http://linkedlifedata.com/resource/pubmed/commentcorrection/19309723-14871971, http://linkedlifedata.com/resource/pubmed/commentcorrection/19309723-14987238, http://linkedlifedata.com/resource/pubmed/commentcorrection/19309723-15144948, http://linkedlifedata.com/resource/pubmed/commentcorrection/19309723-15310767, http://linkedlifedata.com/resource/pubmed/commentcorrection/19309723-15955900, http://linkedlifedata.com/resource/pubmed/commentcorrection/19309723-16051952, http://linkedlifedata.com/resource/pubmed/commentcorrection/19309723-16763282, http://linkedlifedata.com/resource/pubmed/commentcorrection/19309723-16911776, http://linkedlifedata.com/resource/pubmed/commentcorrection/19309723-17538163, http://linkedlifedata.com/resource/pubmed/commentcorrection/19309723-17761983, http://linkedlifedata.com/resource/pubmed/commentcorrection/19309723-2112183, http://linkedlifedata.com/resource/pubmed/commentcorrection/19309723-2160919, http://linkedlifedata.com/resource/pubmed/commentcorrection/19309723-7522962, http://linkedlifedata.com/resource/pubmed/commentcorrection/19309723-8280659, http://linkedlifedata.com/resource/pubmed/commentcorrection/19309723-8669836, http://linkedlifedata.com/resource/pubmed/commentcorrection/19309723-8922205, http://linkedlifedata.com/resource/pubmed/commentcorrection/19309723-9374223, http://linkedlifedata.com/resource/pubmed/commentcorrection/19309723-9529011
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1097-0347
pubmed:author
pubmed:copyrightInfo
Copyright 2009 Wiley Periodicals, Inc.
pubmed:issnType
Electronic
pubmed:volume
31
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1006-12
pubmed:dateRevised
2010-9-22
pubmed:meshHeading
pubmed-meshheading:19309723-Humans, pubmed-meshheading:19309723-Follow-Up Studies, pubmed-meshheading:19309723-Aged, pubmed-meshheading:19309723-Quinazolines, pubmed-meshheading:19309723-Prognosis, pubmed-meshheading:19309723-Female, pubmed-meshheading:19309723-Male, pubmed-meshheading:19309723-Probability, pubmed-meshheading:19309723-Treatment Outcome, pubmed-meshheading:19309723-Adult, pubmed-meshheading:19309723-Carcinoma, Adenoid Cystic, pubmed-meshheading:19309723-Salivary Gland Neoplasms, pubmed-meshheading:19309723-Middle Aged, pubmed-meshheading:19309723-Infusions, Intravenous, pubmed-meshheading:19309723-Neoplasm Invasiveness, pubmed-meshheading:19309723-Dose-Response Relationship, Drug, pubmed-meshheading:19309723-Reference Values, pubmed-meshheading:19309723-Neoplasm Staging, pubmed-meshheading:19309723-Drug Administration Schedule, pubmed-meshheading:19309723-Tumor Markers, Biological, pubmed-meshheading:19309723-Survival Analysis, pubmed-meshheading:19309723-Maximum Tolerated Dose, pubmed-meshheading:19309723-Gene Amplification, pubmed-meshheading:19309723-Receptor, Epidermal Growth Factor
More...